Luca Posa, Pharm.D.

Affiliations: 
2010-2014 Pharmacology Università di Bologna, Bologna, Italy 
 2012-2013 CNRS & Université Paris Descartes 
 2014-2015 Pharmacology CHU Ste. Justine, Universite de Montreal, Montréal, Québec, Canada 
 2015- Psychiatry McGill University, Montreal, QC, Canada 
Area:
opioid, melatonin, pain, tolerance
Google:
"Luca Posa"
Mean distance: 17.56 (cluster 32)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

López-Canul M, Min SH, Posa L, et al. (2019) Melatonin MT and MT Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle. International Journal of Molecular Sciences. 20
De Gregorio D, Enns JP, Nuñez NA, et al. (2018) d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. Progress in Brain Research. 242: 69-96
De Gregorio D, McLaughlin RJ, Posa L, et al. (2018) Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain. Pain
Posa L, De Gregorio D, Gobbi G, et al. (2017) Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain. Current Medicinal Chemistry
De Gregorio D, Comai S, Posa L, et al. (2016) d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. International Journal of Molecular Sciences. 17
De Gregorio D, Posa L, Ochoa-Sanchez R, et al. (2016) The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors. Pharmacological Research. 113: 81-91
Posa L, Accarie A, Noble F, et al. (2015) Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp)
See more...